chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dropped weight; Sore neck; Swollen lymph nodes; Chills; Right side from ear down to shoulder was tight, sore and very uncomfortable; Right side from ear down to shoulder was tight, sore and very uncomfortable; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), EAR PAIN (Right side from ear down to shoulder was tight, sore and very uncomfortable), EAR DISCOMFORT (Right side from ear down to shoulder was tight, sore and very uncomfortable), ABNORMAL LOSS OF WEIGHT (Dropped weight) and NECK PAIN (Sore neck) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 12-Feb-2021, the patient experienced EAR PAIN (Right side from ear down to shoulder was tight, sore and very uncomfortable), EAR DISCOMFORT (Right side from ear down to shoulder was tight, sore and very uncomfortable) and CHILLS (Chills). On 23-Feb-2021, the patient experienced ABNORMAL LOSS OF WEIGHT (Dropped weight), NECK PAIN (Sore neck) and LYMPHADENOPATHY (Swollen lymph nodes). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 daily. At the time of the report, PAIN IN EXTREMITY (Sore arm), EAR PAIN (Right side from ear down to shoulder was tight, sore and very uncomfortable), EAR DISCOMFORT (Right side from ear down to shoulder was tight, sore and very uncomfortable), ABNORMAL LOSS OF WEIGHT (Dropped weight), NECK PAIN (Sore neck), CHILLS (Chills) and LYMPHADENOPATHY (Swollen lymph nodes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, C-reactive protein increased: high (High) CRP were high.. On an unknown date, Red blood cell sedimentation rate increased: high (High) ESR were high.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No relevant concomitant medication was reported.   This case was linked to MOD-2021-036697.; Sender's Comments:  MOD-2021-036697:
Information has been received from a physician concerning a 71 year old male who on 01-FEB-2008 was vaccinated SC with a dose of ZOSTAVAX (Oka/Merck). Concomitant therapy included ARICEPT, LEXAPRO, FLOMAX and digoxin. Seven to ten days after vaccination, on approximately 08-FEB-2008 the patient developed shingles. The patient was advised to and did visit a dermatologist. There were no lab studies performed. Subsequently, the patient recovered after visiting the dermatologist. There was no product quality complaint involved. No further information was provided. Additional information has been requested.
Flushed warm face, chills, aches, nausea, headaches, overall weakness. Flu-like symptons. Lasted two days.
A few minutes into observation period after the shot, the patient came to the counter, said he felt faint, then collapsed onto the floor. He was disoriented but still breathing and conscious. He was moved into a seated position in a chair, where he proceeded to collapse out of the chair again. An ambulance was called, the EMT staff noted all of his vitals were normal and he stated he felt fine again after they had checked him out.
Janssen COVID-19 Vaccine EUA  - 102 Fever - Chills - Aches - Headache - Bloody Nose - Pain in legs and back
Vaccine not administered correctly; A spontaneous report was received from a physician who was also a male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and the vaccine was not administered correctly.   The patient's medical history was not provided. No relevant concomitant medications were reported.    On 23 Jan 2021, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 23 Jan 2021, the patient reported that he doesn't think the vaccine was administered correctly. He stated that he had no arm tenderness or pain after receiving the vaccine.  No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   The event, vaccine not administered correctly, was resolved on 23 Jan 2021.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 (lot # unknown) with no associated AEs reported.
Delayed Swelling bruise; Delayed itchy brusie; Delayed red bruise; Tiny bruise the size of a penny; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (Tiny bruise the size of a penny), VACCINATION SITE SWELLING (Delayed Swelling bruise), INJECTION SITE PRURITUS (Delayed itchy brusie) and INJECTION SITE ERYTHEMA (Delayed red bruise) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced INJECTION SITE BRUISING (Tiny bruise the size of a penny). On 19-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Delayed Swelling bruise), INJECTION SITE PRURITUS (Delayed itchy brusie) and INJECTION SITE ERYTHEMA (Delayed red bruise). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE BRUISING (Tiny bruise the size of a penny), VACCINATION SITE SWELLING (Delayed Swelling bruise), INJECTION SITE PRURITUS (Delayed itchy brusie) and INJECTION SITE ERYTHEMA (Delayed red bruise) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment information includes ice.  No concomitant medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: ADR Form received on 11-MAY-2021 Contains patient details updated , medical history was updated.
So about ten days after the second I woke up and noticed eczema legions on my elbows and the corner of my eyes. I have had this for a long time and had not had a flare up for about two years. I started using the medicine I had and contacted my dermatologist. They gave me a steroid cream and I started that two days after I noticed the flare up and that started to clear it up.
This is a spontaneous report obtained from a contactable medical assistant calling on behalf of a physician and from a contactable nurse. A 18-year-old female patient received the first dose of TRUMENBA, (Lot. M74091, Expiration date: 01Jun2017) on 04Aug2016 at 16:50, intramuscular, in left arm, 0.5 ml single, for immunization. Ongoing relevant medical history included ADHD (attention deficit/hyperactivity disorder) from 20Nov2007 and anxiety. Concomitant medications included CONCERTA 54 mg, once daily, from 30Dec2014 (ongoing) for ADHD, oral FOCALIN 10 mg, once daily, from 21Dec2015 (ongoing) for ADHD and oral sertraline 50 mg, once daily, from 02Aug2016 for anxiety. On 04Aug2016 the patient experienced a significant localized reaction with redness and swelling at the injection area. The patient recovered from the events on an unknown date in 2016. The reporting nurse stated that the patient came in for primary care physician to look at and was not admitted to hospital. Events were considered related to meningococcal group b rlp2086 by the reporting medical assistant and by the reporting nurse. Follow-up (08Oct2016): Follow-up attempts are completed.  No further information is expected. Follow-up (06Dec2016): New information from a contactable nurse: suspect vaccine details, events details, causality assessment.
Initially I had a sore arm for 3 days and it went away. About a week later I started getting a red splotches on my arm where the injection site is. The red splotch is warm to the touch. It comes and goes.
I woke up at 1:15am on 6/25/2022 with gunk in my throat.  I was concerned I would choke if I went back to sleep.  I did fall asleep and woke up later in the morning with a cough, not feeling well. Late afternoon I felt like I had a fever, took my temperature and it was 102.  I took a home COVID test and it was negative.  I took Tylenol for my fever and when I awoke the next morning my fever was gone.  I had a slight headache and felt poorly, cough continued and unable to breath out of either side of my nose. I took another COVID test and it was positive.  I called the nurse line at insurance company and was advised to isolate for 5 days, then wear a mask for the next 5 days and call my primary care doctor first thing the next morning to see about COVID pills. My husband contacted our primary care doctor and spoke to his nurse relaying my symptoms and positive COVID test.  She talked to the doctor and he prescribed Paxlovid Tablets (Standard Dose) I took the first dose of medication at 6:30pm on June 27 and have continued twice daily doses at 6:30am and 6:30pm.  I have 2 doses left to take. I'm feeling much better.
Information has been received from a nurse practitioner concerning a 35 year old female patient with a Demerol allergy who in approximately 1988 was vaccinated with a booster dose of MMR when she entered nursing school. She received a first dose of MMR as a child. In March 2004, the patient had a negative mumps titer and an equivocal result for measles. Additional information has been requested.
Pt called on 5/9/01 to report persisting weakness and nausea. "Feeling debilitated since Typhoid vaccine on 4/24/01 at 09:00. Awoke at 23:00 with severe headache all over "thought it was aneurysm" lasted hours, red chest rash for 2 1/2 days; nausea and debilitating feeling persists. Usually acting on treadmill for exercise. Has pushed to take walks past days to prepare for trip but no strength. Can't resume normal eating and exercises secondary to symptoms.
Suspected vaccination failure; shingles. I still get them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the consumer for herself or himself. The age at vaccination was not reported. The patient reported that, he or she was received the Shingles vaccine for shingles and still get them all of the time. This case was considered as suspected vaccination failure, since the details regarding the time to onset for event and laboratory confirmation for shingles were not provided. The follow-up would not possible as no contact details were available.
pt states that he started having twitches in his right eye.  He says it will twitch for about 30 seconds so he relaxes so it will settle down.  He is having these symptoms multiple times a day.  He will contact his PCP if symptoms persist.
side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history information was provided.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (side effect). At the time of the report, ADVERSE REACTION (side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No information about concomitants was provided.  No information about treatment medication was provided.
Information has been received from a registered nurse concerning an 8 year old female patient who on 09/04/96 was vaccinated with a dose of Varivax. On 12/27/01, the patient was diagnosed with a mild case of chickenpox (start date of event not reported). It was noted that a rash with less than 20 lesions was the only symptom reported. Unspecified medical attention was sought. Additional information has been requested.
Sensation of throat swelling.  Left after 15 minute monitoring period and returned with complaints.  ADministered 50mg Benedryl IM and observed for 30  minutes,  REleased with spouse
Pain at injection site (began at 6pm 3/12, resolved around 8am 3/15) Fever (began at 11pm 3/12, peaked at 102.0F at 3am 3/13, and resolved at noon 3/14) Fatigue, muscle pains, nausea, chills (began around 3am 3/13, resolved around 5pm 3/14) Chest tightness / difficulty breathing (began 9pm 3/13, reduced intensity on 3/15)
I started out with an itchy chin.  The itch then went to my forehead, scalp, cheeks and left ear pinna.  The tip of my tongue also became numb.  Symptoms lasted for 45 minutes.
Fever 100 and above, extreme swollen leg and knee, child unable to walk due to pain.
Information has been received from a certified medical assistant concerning a female patient between 13-16 years old, who was vaccinated with GARDASIL.  The certified medical assistant reported the patient wanted to receive her GARDASIL vaccine while standing up had passed out almost immediately after the vaccine was administered.  Subsequently, the patient recovered and was fine before leaving the office.  No further information is available.
Info has been received from an RN concerning a 10 year old white male with an innocent heart murmur who on 3/22/99 was vaccinated , in the left arm with a 1st dose of varicella virus vaccine live. There was no illness at the time of vaccination. On 3/16/05, the pt developed a rash with approximately 30 papules and vesicles. The rash was also noted to be itchy. Benadryl and Tylenol were recommended for treatment. The outcome was reported as recovered. There were no relevant diagnostic tests or laboratory data. There were no adverse events following prior vaccinations. No additional info is expected.
Less than 2 hours after injection, patient developed urticaria on righ thigh.  Waxed and waned.  Next morning had urticaria on right thigh, left thigh, and lower extremities.  Seen in clinic.  No signs of systemic reaction.  No recent URI, no other symoptoms at this time.
This spontaneous case was reported by a consumer and describes the occurrence of CONSTIPATION (Constipation), URTICARIA (Welts in her armpit) and RASH (Rash on face) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect products included non-company products MIRABEGRON (MYRBETRIQ) tablet for Hypertonic bladder and LINACLOTIDE (LINZESS) tablet for an unknown indication. The patient's past medical history included Constipation. Previously administered products included for Bladder disorder: Trospium. Past adverse reactions to the above products included Constipation with Trospium. Concurrent medical conditions included Drug allergy (Sulfa allergy, cannot take bactrim) and Hypertonic bladder. Concomitant products included CALAMINE, DIPHENHYDRAMINE HYDROCHLORIDE (CALADRYL [CALAMINE; DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication. On 10-Jan-2022, the patient started MIRABEGRON (MYRBETRIQ) (unknown route) 50 milligram once a day. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and LINACLOTIDE (LINZESS) (unknown route) at an unspecified dose. On an unknown date, the patient experienced CONSTIPATION (Constipation), URTICARIA (Welts in her armpit) and RASH (Rash on face). At the time of the report, CONSTIPATION (Constipation) and RASH (Rash on face) outcome was unknown and URTICARIA (Welts in her armpit) was resolving. No lab test information was provided. It was reported that, the patient took Trospium before mirabegron for her bladder problem, but the patient had constipation after taking this, so her doctor changed it to mirabegron. The patient stated that, she pees 800 miles per hour unless she took medicine for overactive bladder. The patient also reported that, after taking mirabegron for 2.5 to 3 weeks, she had welts in her armpits, six in one and three in another armpit. The welts looked like a spider bite. The patient stopped taking both mirabegron and linaclotide on 29 Jan 2022 and started taking Caladryl and so far this helped with the welts. The patient had no angioedema or symptoms of angioedema. The patient was trying to decide whether she should re challenge or took either mirabegron or Linzess first to see which one caused the problem of the welts in her armpit. Action taken with mirabegron treatment with response to events was discontinued on 29 Jan 2022. Action taken with linaclotide treatment was withdrawn. No treatment information was provided.
Initial report was received from a health care professional on 24 September 2010. A 78 year-old female patient with no illness at the time of vaccination, had received an intramuscular left deltoid injection of FLUZONE HIGH-DOSE, lot number U3600AA on 16 September 2010 and "two hours" later, experienced a cough and sore throat. She reported staying in bed "all day". On 17 September 2010, "the next day" she woke up "covered" with a rash. No treatments were reported. On 22 September 2010 the patient reported the rash was "fading". No further information was provided at the time of the report. The patient's outcome was not reported. Follow-up information was received from health care professional on 22 October 2010. The patient's outcome was reported as recovered. No further information was provided at the time of the report. Documents held by sender: none.
Narrative:  Patient received vaccination on 12/31/ 2020 and reports on 1/6/2021 that he had vivid dream/hallucination approximately the next evening after receiving vaccination and then reports having another vivid dream/hallucination on the 3rd day post-vaccination. Pt did not receive any treatment medication for vivid dream/hallucination. Pt does not have any noted history of hallucinations in the past. Current orders in place by provider: Labs, UA/ C&S, I&O Q4H, NEURO CHECK Q4H, VS Q4H. PMH: recurrent major depressive disorder, adjustment disorder with depressed mood. Symptoms:  Hallucinations & VIVID DREAM Treatment:
RED SPOT PAINFUL/RED/SWOLLEN AND HOT TOUCH; ARM SORENESS; ACTIVITIES OF DAILY LIVING AFFECTED; This spontaneous report received from a patient concerned a 25 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 expiry: 20-JUN-2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced activities of daily living affected. On 06-APR-2021, the subject experienced arm soreness. On 07-APR-2021, the subject experienced red spot painful/red/swollen and hot touch. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red spot painful/red/swollen and hot touch, and the outcome of arm soreness and activities of daily living affected was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
patient reports red, sore, itchy arm for 10 days. referred to physicians office for further treatment and evaluation.
Neck stiffness/left jaw pain and stiffness within 1 hour of administion, lasting all day. Around 2100 the same night, rapidly progressing paresthesia of complete left face without obvious facial palsy yet (numbness happened over the course of about 30min to the point where I had no perception of touch in the left face).  At this point I took 60mg of prednisone and went to bed. When I woke up, the paresthesia/stiffness was less and progressively so since finishing a course of prednisone.   Concerned that this could have been a bells palsy reaction to the vaccine.
6 days after vaccination, on Sunday June 26th, started to develop red itchy spots on lower legs and left arm. Patient thought this was poison ivy contamination. The itching and red spots spread and on Wed July 6th patient visited a nurse practitioner who diagnosed poison ivy and prescribed prednazolone (60 mg first day, 50 mg 2nd day, etc until 10 mg 6th day). and Betamethasone Dipropionate ointment.  This helped and red spots and itching went down. But on Tuesday July 12th, while flying, red spots increased quickly again, with many spots on my hands and feet, and red areas over belly and back. So on Wednesday July 13th I visited a doctor, who sent me to the hospital on Thursday July 14th to visit a dermatologist.  The dermatologist diagnosed Erythema Multiforme - minor form, a skin condition caused by overreacting of the immune system. He prescribed prednozolone again, now 80 mg per day for 4 days.  This helped to get rid of the red spots in 5 days, and I have now fully recovered.  The dermatologist was not sure what triggered this condition. Could be the vaccine, could be the poison ivy, could be another virus.  I have a medical report from the dermatologist and pictures of my body in case this is of interest to the CDC.
I received the Zostavax Vial vacine on 11/6/08.  I do not see it listed in the list of vacines below.  I had a fever on Tuesday, 11/11/08, which disappeared within a few hours, and last night, 11/12/08 the injection site became red and began itching.
After the 1st dose of the Moderna vaccine in the left arm, patient has not been able to lift or mover her left arm.; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (After the 1st dose of the Moderna vaccine in the left arm, patient has not been able to lift or mover her left arm.) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01417201A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced MOVEMENT DISORDER (After the 1st dose of the Moderna vaccine in the left arm, patient has not been able to lift or mover her left arm.). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, MOVEMENT DISORDER (After the 1st dose of the Moderna vaccine in the left arm, patient has not been able to lift or mover her left arm.) outcome was unknown.            No concomitant medications provided. Treatment included other pain medication.  She was seen by her doctor in September 2021 and has had an MRI and other tests done etc. A definite cause or diagnosis was not provided regarding her left arm. She is currently under doctor's care.   This case was linked to MOD-2021-408579 (Patient Link).